Fmoc-3-(4-pyridyl)-D-alanine is a non-natural, protected amino acid derivative. Its structure features a D-alanine backbone with a 4-pyridyl substituent at the β-position and an N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) protecting group. This configuration makes it a chiral, heterocyclic building block. This compound is primarily employed in solid-phase peptide synthesis (SPPS) using the Fmoc strategy. The 4-pyridyl side chain introduces a basic, aromatic heterocycle into peptide sequences, which can be crucial for modulating peptide properties such as binding affinity, solubility, and conformational stability. It is specifically used to incorporate this unique, non-proteinogenic amino acid into peptides for pharmaceutical research, particularly in the development of peptide-based drugs, enzyme inhibitors, and probes for studying protein-protein interactions. The D-configuration of the alanine center provides resistance to enzymatic degradation by common proteases, which is a valuable feature for creating metabolically stable therapeutic peptides. Its use is specialized within medicinal chemistry and chemical biology for constructing peptides with tailored biological activities and physicochemical profiles.